K, V., J, A., TW, W., A, M., S, R., J, V., . . . K, W. (2024). Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. The Journal of clinical investigation, 134(9), . https://doi.org/10.1172/JCI169315
Chicago Style (17th ed.) CitationK, Vaccaro, et al. "Targeted Therapies Prime Oncogene-driven Lung Cancers for Macrophage-mediated Destruction." The Journal of Clinical Investigation 134, no. 9 (2024). https://doi.org/10.1172/JCI169315.
MLA (9th ed.) CitationK, Vaccaro, et al. "Targeted Therapies Prime Oncogene-driven Lung Cancers for Macrophage-mediated Destruction." The Journal of Clinical Investigation, vol. 134, no. 9, 2024, https://doi.org/10.1172/JCI169315.
Warning: These citations may not always be 100% accurate.